Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats (Q28580246)

2

1 reference

31 January 2017

Sang Youb Han

3

1 reference

31 January 2017

Mi Hwa Lee

4

1 reference

31 January 2017

Hye Kyoung Song

5

1 reference

31 January 2017

Kum Hyun Han

6

1 reference

31 January 2017

Hyoung Kyu Kim

7

1 reference

31 January 2017

Jee Young Han

8

1 reference

31 January 2017

Dae Ryong Cha

Nephrology Dialysis Transplantation

9

1 reference

31 January 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

31 January 2017

1 reference

31 January 2017

23

1 reference

31 January 2017

2750–2760

1 reference

31 January 2017

9

1 reference

31 January 2017

Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

Effect of retinoic acid in experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

Peroxisome proliferator-activated receptors: nuclear control of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

Peroxisome proliferator-activated receptor gamma and metabolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

An overview on biological mechanisms of PPARs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

Agonist of peroxisome proliferator-activated receptor-gamma, rosiglitazone, reduces renal injury and dysfunction in a murine sepsis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

Peroxisome Proliferator-Activated Receptor γ Agonist Provides Superior Renal Protection versus Angiotensin-Converting Enzyme Inhibition in a Rat Model of Type 2 Diabetes with Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

Use of a cDNA microarray to analyse gene expression patterns in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

Rosiglitazone reduces urinary albumin excretion in type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

Anti-inflammatory effects of short-term pioglitazone therapy in men with advanced diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

Peroxisome proliferator-activated receptor gamma agonists in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN157

https://api.fatcat.wiki/v0/release/t6jpplaxx5gslantzrd2k3m73m

21 January 2018

Identifiers

1 reference

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_t6jpplaxx5gslantzrd2k3m73m

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t6jpplaxx5gslantzrd2k3m73m

mapped directly with Wikidata item

30 July 2022

based on heuristic

1 reference

https://api.fatcat.wiki/v0/release/t6jpplaxx5gslantzrd2k3m73m